In contrast, the introduction of a monoclonal somatostatin antibody resulted in only partial inhibition [50, 51]
Some insurance providers may require prior authorization for weight loss drug coverage
When clinically appropriate, care plans may include GLP-1-based therapies such as compounded tirzepatide or semaglutide
Starting July 1, 2026, Medicare will offer more affordable access to certain weight loss medications through a temporary program called the Medicare GLP-1 Bridge
The proposed sale of most of Elixir, while needed to provide capital, leaves an enterprise with even fewer growth opportunities. In fiscal 2023, Rite Aid totaled more than $24 billion in revenue, and the company fills roughly 200 million prescriptions annually and employs over 45,000 people